DiviDrip · ENSC

ENSC — Ensysce Biosciences, Inc. Common Stock

ENSC is Ensysce Biosciences, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $0.44. Market cap: $8M. Capital Quality Rank: 35/100 — Stagnant mediocrity.

Stock snapshot

Price$0.44
Market cap$8M
SectorHealthcare
Exchange
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)35 / 100 · Stagnant mediocrity
Revenue CAGR (3y)26.2%
Shareholder buyback yield-8.98%
Altman Z-score zoneDistress

About ENSC

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Listed2021Employees10HQLa Jolla, CASectorHealthcareWebsiteensysce.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ENSC. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ENSC's current stock price?

ENSC (Ensysce Biosciences, Inc. Common Stock) is currently trading at $0.44.

Does ENSC pay a dividend?

ENSC (Ensysce Biosciences, Inc. Common Stock) does not currently pay a regular dividend.

What is ENSC's Capital Quality Rank?

ENSC has a Capital Quality Rank of 35/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ENSC in DiviDrip

Add ENSC to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed recently. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow